Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
782.29
648.41
520.32
406.14
397.16
381.54
307.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
782.29
648.41
520.32
406.14
397.16
381.54
307.51
Raw Material Cost
368.58
329.00
332.40
263.84
216.22
211.43
149.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
99.46
92.76
89.02
70.99
74.20
67.30
48.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.46
8.50
8.21
6.41
7.41
0.84
1.39
Selling and Distribution Expenses
185.74
161.55
120.15
105.94
110.03
119.17
95.16
Other Expenses
-10.39
-10.13
-9.72
-7.74
-8.16
-6.81
-4.95
Total Expenditure (Excl Depreciation)
554.33
490.55
452.55
369.78
326.25
330.59
245.23
Operating Profit (PBDIT) excl Other Income
228
157.89999999999998
67.8
36.4
70.9
50.9
62.300000000000004
Other Income
18.10
16.34
14.18
5.08
1.25
8.09
4.24
Operating Profit (PBDIT)
298.35
220.73
125.58
89.23
115.77
94.90
96.20
Interest
4.46
8.50
8.21
6.41
7.41
0.84
1.39
Exceptional Items
0.00
0.00
5.09
-2.50
-21.89
-7.19
0.00
Gross Profit (PBDT)
413.71
319.42
187.92
142.30
180.94
170.12
157.68
Depreciation
52.28
46.52
43.63
47.78
43.60
35.86
29.68
Profit Before Tax
241.60
165.71
78.83
32.54
42.87
51.00
65.13
Tax
38.98
27.68
13.57
7.42
11.06
9.67
10.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
197.26
130.46
57.09
24.62
22.60
41.02
52.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
197.26
130.46
57.09
24.62
22.60
41.02
52.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.43
6.75
6.24
-1.29
8.02
3.27
6.81
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.69
137.21
63.33
23.33
30.62
44.30
59.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.0
0.0
Reserves
1,082.02
970.68
985.51
929.20
904.71
657.33
147.64
Earnings per share (EPS)
0.24
0.15
0.06
0.03
0.03
0.0
0.0
Diluted Earnings per share
0.24
0.15
0.06
0.03
0.03
0.0
0.0
Operating Profit Margin (Excl OI)
29.14%
24.35%
13.02%
8.95%
17.85%
13.35%
20.25%
Gross Profit Margin
37.57%
32.73%
23.54%
19.78%
21.77%
22.77%
30.83%
PAT Margin
25.22%
20.12%
10.97%
6.06%
5.69%
10.75%
17.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 20.65% vs 24.62% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 47.74% vs 116.75% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 37.08% vs 83.48% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -47.06% vs 3.66% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of JBM (Healthcare) Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
782.29
1,576.90
-794.61
-50.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
782.29
1,576.90
-794.61
-50.39%
Raw Material Cost
368.58
883.96
-515.38
-58.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
99.46
473.05
-373.59
-78.97%
Power Cost
0
0
0.00
Manufacturing Expenses
4.46
41.37
-36.91
-89.22%
Selling and Distribution Expenses
185.74
322.00
-136.26
-42.32%
Other Expenses
-10.39
-51.22
40.83
79.71%
Total Expenditure (Excl Depreciation)
554.33
1,208.19
-653.86
-54.12%
Operating Profit (PBDIT) excl Other Income
227.97
368.70
-140.73
-38.17%
Other Income
18.10
77.63
-59.53
-76.68%
Operating Profit (PBDIT)
298.35
590.20
-291.85
-49.45%
Interest
4.46
41.37
-36.91
-89.22%
Exceptional Items
0.00
-31.73
31.73
100.00%
Gross Profit (PBDT)
413.71
692.94
-279.23
-40.30%
Depreciation
52.28
143.87
-91.59
-63.66%
Profit Before Tax
241.60
373.23
-131.63
-35.27%
Tax
38.98
72.79
-33.81
-46.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
197.26
300.83
-103.57
-34.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
197.26
300.83
-103.57
-34.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
5.43
0.00
5.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.69
300.83
-98.14
-32.62%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
1,082.02
2,453.22
-1,371.20
-55.89%
Earnings per share (EPS)
0.24
0.15
0.09
60.00%
Diluted Earnings per share
0.24
0.15
0.09
60.00%
Operating Profit Margin (Excl OI)
29.14%
23.38%
0.00
5.76%
Gross Profit Margin
37.57%
32.79%
0.00
4.78%
PAT Margin
25.22%
19.08%
0.00
6.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 78.23 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 20.65% vs 24.62% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 20.27 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 47.74% vs 116.75% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.02 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 37.08% vs 83.48% in Mar 2024
Annual - Interest
Interest 0.45 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -47.06% vs 3.66% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.14%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






